VIM and colorectal carcinoma: In this study, we present evidence that CRC cells exposed to the chemotherapeutic drug (5-FU) (either transient exposure or 5-FU-R cells) gradually develop EMT phenotypes along with amplified Vimentin expression and invasive properties.